A naturally occurring signaling molecule called C-type natriuretic peptide, or CNP, was shown to reduce the severity of PAH.
Cereno is planning to launch a new Phase 1 clinical trial to evaluate the pharmacological properties of CS014 in healthy ...
Living with PH feels like an endless financial balancing act, leaving columnist Jen Cueva constantly on the verge of going ...
Scientists have uncovered key genetic drivers behind blood vessel damage in idiopathic PAH, according to a study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results